The mycolyltransferase 85A, a putative drug target of Mycobacterium tuberculosis: development of a novel assay and quantification of glycolipid-status of the mycobacterial cell wall.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Name:
Supplemental Materials.pdf
Size:
93.98Kb
Format:
PDF
Description:
Supplemental material
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Issue Date
2009-12
Metadata
Show full item recordAbstract
The enzymes of the antigen 85 complex (Ag85A, B, and C) possess mycolyltransferase activity and catalyze the synthesis of the most abundant glycolipid of the mycobacterial cell wall, the cord factor. The cord factor (trehalose 6,6'-dimycolate, TDM) is essential for the integrity of the mycobacterial cell wall and pathogenesis of the bacillus. Thus, TDM biosynthesis is regarded as a potential drug target for control of Mycobacterium tuberculosis infections. Trehalose 6,6'-dimycolate (TDM) is synthesized from two molecules of trehalose-6'-monomycolate (TMM) by antigen 85A. We report here a novel enzyme assay using the natural substrate TMM. The novel colorimetric assay is based on the quantification of glucose from the degradation of trehalose, which is the product from catalytic activity of antigen 85A. Using the new assay, K(m) and K(cat) were determined with values of 129.6+/-8.1 microM and 65.4+/-4.1 min(-1), respectively. This novel assay is also suitable for robust high-throughput screening (HTS) for compound library screening against mycolyltransferase (antigen 85A). The assay is significantly faster and more convenient to use than all assays currently in use. The assay has a very low coefficient of variance (0.04) in 96-well plates and shows a Z' factor of 0.67-0.73, indicating the robustness of the assay. In addition, this new assay is highly suitable for the quantification of total TMM of the mycobacterial cell envelope.Citation
The mycolyltransferase 85A, a putative drug target of Mycobacterium tuberculosis: development of a novel assay and quantification of glycolipid-status of the mycobacterial cell wall. 2009, 79 (3):358-63 J. Microbiol. MethodsAffiliation
Department of Genome Analysis, Helmholtz Centre for Infection Research, 38124 Braunschweig, Germany.PubMed ID
19857528Type
ArticleLanguage
enISSN
1872-8359ae974a485f413a2113503eed53cd6c53
10.1016/j.mimet.2009.10.010
Scopus Count
The following license files are associated with this item:
Related articles
- A coupled assay measuring Mycobacterium tuberculosis antigen 85C enzymatic activity.
- Authors: Boucau J, Sanki AK, Voss BJ, Sucheck SJ, Ronning DR
- Issue date: 2009 Feb 1
- The Mycobacterium tuberculosis Ag85A is a novel diacylglycerol acyltransferase involved in lipid body formation.
- Authors: Elamin AA, Stehr M, Spallek R, Rohde M, Singh M
- Issue date: 2011 Sep
- The three Mycobacterium tuberculosis antigen 85 isoforms have unique substrates and activities determined by non-active site regions.
- Authors: Backus KM, Dolan MA, Barry CS, Joe M, McPhie P, Boshoff HI, Lowary TL, Davis BG, Barry CE 3rd
- Issue date: 2014 Sep 5
- Control of cell wall assembly by a histone-like protein in Mycobacteria.
- Authors: Katsube T, Matsumoto S, Takatsuka M, Okuyama M, Ozeki Y, Naito M, Nishiuchi Y, Fujiwara N, Yoshimura M, Tsuboi T, Torii M, Oshitani N, Arakawa T, Kobayashi K
- Issue date: 2007 Nov
- Crystal structure of the secreted form of antigen 85C reveals potential targets for mycobacterial drugs and vaccines.
- Authors: Ronning DR, Klabunde T, Besra GS, Vissa VD, Belisle JT, Sacchettini JC
- Issue date: 2000 Feb